• DOI:10.1007/s10741-014-9452-9
Corpus ID: 11521278

Anderson-Fabry cardiomyopathy: prevalence, pathophysiology, diagnosis and treatment

@article{Putko2014AndersonFabryCP,
  title={Anderson-Fabry cardiomyopathy: prevalence, pathophysiology, diagnosis and treatment},
  author={B. Putko and Kevin C Wen and R. Thompson and J. Mullen and M. Shanks and Haran Yogasundaram and C. Sergi and G. Oudit},
  journal={Heart Failure Reviews},
  year={2014},
  volume={20},
  pages={179-191}
}

B. Putko, Kevin C Wen, +5 authors G. Oudit

Published 2014

Medicine

Heart Failure Reviews

Anderson-Fabry disease (AFD) is a lysosomal storage disease caused by the inappropriate accumulation of globotriaosylceramide in tissues due to a deficiency in the enzyme α-galactosidase A (α-Gal A). Anderson-Fabry cardiomyopathy is characterized by structural, valvular, vascular and conduction abnormalities, and is now the most common cause of mortality in patients with AFD. Large-scale metabolic and genetic screening studies have revealed AFD to be prevalent in populations of diverse ethnic… CONTINUE READING

View on Springer

ncbi.nlm.nih.gov

Save to Library

Create Alert

Cite

Launch Research Feed